mail2

Spectrum Library

Microarray Analysis of lncRNA and mRNA Expression Profiles in Patients with Neuromyelitis Optica.

Publication Date March 2016

Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.

Publication Date January 2016

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.

Publication Date February 2016

A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.

Publication Date February 2016

Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica.

Publication Date May 2016

Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.

Publication Date December 2015

Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.

Publication Date December 2015

Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.

Publication Date February 2016

Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.

Publication Date April 2016

A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder.

Publication Date September 2013

Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab.

Publication Date March 2016

Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Publication Date January 2016

Tags
Recent Comments